Actinium Pharmaceuticals, Inc.
ATNM
$1.25
$0.021.29%
AMEX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 20.92% | -19.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 25.95% | -7.97% | |||
| Operating Income | 566.97% | 7.97% | |||
| Income Before Tax | 605.27% | 7.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 605.27% | 7.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 605.27% | 7.04% | |||
| EBIT | 566.97% | 7.97% | |||
| EBITDA | 576.63% | 7.76% | |||
| EPS Basic | 602.60% | 7.14% | |||
| Normalized Basic EPS | 602.62% | 7.14% | |||
| EPS Diluted | 602.60% | 7.14% | |||
| Normalized Diluted EPS | 602.44% | 7.14% | |||
| Average Basic Shares Outstanding | 0.52% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.54% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||